Accelerating Discovery Through Human Organoid Models
We partner with academic investigators, biotechnology companies, pharmaceutical organizations, and AI-driven biomedical teams to build patient-derived organoid models that enable mechanistic discovery, biomarker development, and therapeutic innovation.
For external collaborations and partnership inquiries, please contact: Jeroen Roose, PhD
UCSF Investigators. UCSF researchers can access UCSF iLab – Organoid Core: https://ucsf.ilab.agilent.com/service_center/show_external/6099?name=organoid-core and contact Michelle Gbenedio, Organoid D2B Core Manager, for onboarding and project assessment.
Resources
Biobanked Patient-derived Organoids (PDO)
Exome-sequence confirmed somatic mutations
Perturbation assays (therapy, viral infection, PDO + immune)
Characterization through patented spectral flow proteomics platform
